Evidence map›Paper›PMID 28323411›Full record

ArticleACS nano2017

Engineering an Injectable Muscle-Specific Microenvironment for Improved Cell Delivery Using a Nanofibrous Extracellular Matrix Hydrogel.

Nikhil Rao, Gillie Agmon, Matthew T Tierney, Jessica L Ungerleider, Rebecca L Braden, Alessandra Sacco, Karen L Christman

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 74 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Nanomedicine, a valuable tool for skeletal muscle disorders: Challenges, promises, and limitations.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Extracellular matrix grafts: From preparation to application (Review).International journal of molecular medicine · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Nikhil RaoDepartment of Bioengineering and Sanford Consortium for Regenerative Medicine, University of California, San Diego , La Jolla, California 92037, United States.
Gillie AgmonDepartment of Bioengineering and Sanford Consortium for Regenerative Medicine, University of California, San Diego , La Jolla, California 92037, United States.
Matthew T Tierney
Jessica L UngerleiderDepartment of Bioengineering and Sanford Consortium for Regenerative Medicine, University of California, San Diego , La Jolla, California 92037, United States.
Rebecca L BradenDepartment of Bioengineering and Sanford Consortium for Regenerative Medicine, University of California, San Diego , La Jolla, California 92037, United States.
Alessandra Sacco
Karen L ChristmanDepartment of Bioengineering and Sanford Consortium for Regenerative Medicine, University of California, San Diego , La Jolla, California 92037, United States.ORCID 0000-0002-6179-898X
University of California San Diego · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Training in Multi-Scale Analysis of Biological Structure and FunctionT32EB009380 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Andrew D. McCulloch, Padmini Rangamani · 2009 to 2026
$4.8M
Integrative Bioengineering of Heart, Vessels, and BloodT32HL105373 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHIEN, SHU, INTAGLIETTA, MARCOS · 2010 to 2019
$3.6M
Extracellular matrix hydrogels for treating ischemiaR01HL113468 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHRISTMAN, KAREN L · 2012 to 2020
$3.1M
Role of STAT3 in muscle stem cell activationR01AR064873 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SACCO, ALESSANDRA · 2014 to 2018
$2.1M
Role of proteoglycan sulfation during muscle regeneration in dystrophic animalsF31AR065923 · NIAMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI TIERNEY, MATTHEW · 2014 to 2016
$63k
NCI NIH HHS P30 CA030199NHLBI NIH HHS R01 HL113468NHLBI NIH HHS T32 HL105373NIAMS NIH HHS F31 AR065923NIAMS NIH HHS R01 AR064873NIBIB NIH HHS T32 EB009380
6 · The paper itself

Abstract

Injection of skeletal muscle progenitors has the potential to be a minimally invasive treatment for a number of diseases that negatively affect vasculature and skeletal muscle, including peripheral artery disease. However, success with this approach has been limited because of poor transplant cell survival. This is primarily attributed to cell death due to extensional flow through the needle, the harsh ischemic environment of the host tissue, a deleterious immune cell response, and a lack of biophysical cues supporting exogenous cell viability. We show that engineering a muscle-specific microenvironment, using a nanofibrous decellularized skeletal muscle extracellular matrix hydrogel and skeletal muscle fibroblasts, improves myoblast viability and maturation in vitro. In vivo, this translates to improved cell survival and engraftment and increased perfusion as a result of increased vascularization. Our results indicate that a combinatorial delivery system, which more fully recapitulates the tissue microenvironment, can improve cell delivery to skeletal muscle.

Indexed as

Tissue EngineeringAnimalsCells, CulturedCellular MicroenvironmentExtracellular MatrixHydrogelsMiceMuscle, SkeletalNanofibersHydrogelsbiomaterialcell deliverycell microenvironmentinjectablemusclemyoblastperipheral artery disease

Identifiers

PMID28323411
PMCPMC5576867
OpenAlexW2599567934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.